Integrating Clinical, Histopathological, and Molecular Predictors of Malignant Transformation in Oral Leukoplakia: A Narrative Review

Mashayu Permatahati1, Theresia Indah Budhy2*

Abstract

The most prevalent potentially cancerous oral condition is oral leukoplakia (OL), but reported rates of malignant transformation (MT) vary widely, which complicates follow-up and management. This narrative review examines clinical, histopathological and molecular predictors of MT in OL, including the consistency of associations, methodological limitations, challenges and research gaps. Pooled MT estimates are about 6.6-7.2% although individual cohorts range from 4% to 21.7%. In pooled analyses, non-homogeneous lesions, lateral tongue location, and epithelial dysplasia are most strongly associated with MT, whereas tobacco and demographics remain inconsistent. DNA ploidy and p53 have the most molecular support but act only as adjuncts, while other markers remain preliminary. Current evidence supports stratifying patients into higher and lower-risk groups however cannot yet predict transformation in individual patients. A consensus-based definition, prospective multicenter cohort studies, and externally validated models are necessary for future study.

Keywords

oral leukoplakia; malignant transformation; oral potentially malignant disorders; dysplasia grading; biomarkers; risk stratification

 

Cite This Article

Permatahati, M., Budhy, T. I. (2026). Integrating Clinical, Histopathological, and Molecular Predictors of Malignant Transformation in Oral Leukoplakia: A Narrative Review. International Journal of Scientific Advances (IJSCIA), Volume 7| Issue 6: Nov – Dec 2026, Pages 1118-1126. URL: https://www.ijscia.com/wp-content/uploads/2026/11/Volume7-Issue6-Nov-Dec-No.1137-1118-1126.pdf

Volume 7 | Issue 6: Nov – Dec 2026